Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Fuller

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
The Lancet. Diabetes & Endocrinology|November 14, 2025
Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: a systematic review and meta-analysisSho Katsuragawa, Minh V Le, Peter J Fuller, et al.
The Journal of Endocrinology|December 14, 2011
Mechanisms of ligand specificity of the mineralocorticoid receptorPeter J Fuller, Yizou Yao, Jun Yang, et al.
Journal of Human Hypertension|April 29, 2020
Primary aldosteronism is a public health issue: challenges and opportunitiesRenata Libianto, Peter J Fuller, Morag J Young, et al.
Journal of Human Hypertension|August 1, 2020
Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heartMorag J Young, Monica Kanki, Peter J Fuller, et al.
Endocrine Reviews|June 17, 2016
Bone Disease in Thalassemia: A Molecular and Clinical OverviewPhillip Wong, Peter J Fuller, Matthew T Gillespie, et al.
Molecular and Cellular Endocrinology|June 5, 2002
Molecular pathogenesis of granulosa cell tumoursPeter J Fuller, Simon Chu, Sonay Fikret, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 9, 2023
Improving Detection Rates for Primary AldosteronismRenata Libianto, Michael Stowasser, Grant Russell, et al.
Clinical and Experimental Pharmacology & Physiology|November 24, 2004
Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptorFraser M Rogerson, Yizhou Yao, Brian J Smith, et al.
Molecular Endocrinology (Baltimore, Md.)|May 25, 2004
Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cellsSimon Chu, Yoshihiro Nishi, Toshihiko Yanase, et al.
Clinical and Experimental Pharmacology & Physiology|October 15, 2013
Introduction: Aldosterone and salt: heart and kidneyMorag J Young, Peter J Fuller, Michael Stowasser, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
The Lancet. Diabetes & Endocrinology|November 14, 2025
Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: a systematic review and meta-analysisSho Katsuragawa, Minh V Le, Peter J Fuller, et al.
The Journal of Endocrinology|December 14, 2011
Mechanisms of ligand specificity of the mineralocorticoid receptorPeter J Fuller, Yizou Yao, Jun Yang, et al.
Journal of Human Hypertension|April 29, 2020
Primary aldosteronism is a public health issue: challenges and opportunitiesRenata Libianto, Peter J Fuller, Morag J Young, et al.
Journal of Human Hypertension|August 1, 2020
Identifying new cellular mechanisms of mineralocorticoid receptor activation in the heartMorag J Young, Monica Kanki, Peter J Fuller, et al.
Endocrine Reviews|June 17, 2016
Bone Disease in Thalassemia: A Molecular and Clinical OverviewPhillip Wong, Peter J Fuller, Matthew T Gillespie, et al.
Molecular and Cellular Endocrinology|June 5, 2002
Molecular pathogenesis of granulosa cell tumoursPeter J Fuller, Simon Chu, Sonay Fikret, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 9, 2023
Improving Detection Rates for Primary AldosteronismRenata Libianto, Michael Stowasser, Grant Russell, et al.
Clinical and Experimental Pharmacology & Physiology|November 24, 2004
Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptorFraser M Rogerson, Yizhou Yao, Brian J Smith, et al.
Molecular Endocrinology (Baltimore, Md.)|May 25, 2004
Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cellsSimon Chu, Yoshihiro Nishi, Toshihiko Yanase, et al.
Clinical and Experimental Pharmacology & Physiology|October 15, 2013
Introduction: Aldosterone and salt: heart and kidneyMorag J Young, Peter J Fuller, Michael Stowasser, et al.
Pageof 21